Ironwood shareholders elect nine directors, approve executive pay, ratify auditor at 2024 annual meeting

IRONWOOD PHARMACEUTICALS INC

All nine director nominees elected with over 130 million votes each for a one-year term.
Advisory vote on executive compensation passed with ~127.4 million for, ~8.0 million against.
Ratification of Ernst & Young as auditor for 2024 approved with ~136.8 million for, ~6.3 million against.
Meeting held June 18, 2024; all proposals received majority support.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.